AstraZeneca

1.733,50 SEK

+0,93%

Mindre end 1K følgere

AZN

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AstraZeneca

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

Udbytteprocent

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)940,20828,401.062,801.403,501.353,501.446,501.703,50
Aktier1.301,01.312,01.496,01.548,01.549,11.550,51.550,9
Markedsværdi1.223.200,21.086.860,81.589.948,82.172.618,02.096.719,42.242.865,12.641.971,7
Enterprise value1.334.526,31.186.261,51.810.164,12.413.327,92.328.524,32.516.469,0-
EV/S6,15,45,35,25,04,2-
EV/EBITDA21,317,426,425,017,013,7-
EV/EBIT48,828,0189,361,628,222,8-
P/E98,041,41.567,263,434,928,928,1
P/B8,968,474,475,625,314,985,90
P/S5,65,04,74,74,53,84,9
Udbytteprocent2,8 %1,8 %2,4 %2,2 %2,2 %2,4 %1,7 %
Equity ratio23,8 %23,4 %37,3 %38,4 %38,7 %39,3 %42,7 %
Gearing ratio124,9 %130,3 %74,7 %78,9 %73,6 %74,1 %60,8 %